[DPHARMA] QoQ Annualized Quarter Result on 30-Sep-2013 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
19-Nov-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
30-Sep-2013 [#3]
Profit Trend
QoQ- -7.31%
YoY- 20.77%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Revenue 162,236 161,980 162,405 155,561 151,652 151,348 135,310 12.89%
PBT 42,604 44,700 40,175 41,356 43,926 35,824 35,298 13.40%
Tax -10,820 -11,240 -7,900 -9,122 -9,150 -9,028 -9,284 10.77%
NP 31,784 33,460 32,275 32,233 34,776 26,796 26,014 14.33%
-
NP to SH 31,784 33,460 32,275 32,233 34,776 26,796 26,014 14.33%
-
Tax Rate 25.40% 25.15% 19.66% 22.06% 20.83% 25.20% 26.30% -
Total Cost 130,452 128,520 130,130 123,328 116,876 124,552 109,296 12.55%
-
Net Worth 179,045 190,050 181,850 179,125 187,340 176,143 169,354 3.78%
Dividend
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Div 11,103 - 24,293 - 11,101 - 19,434 -31.21%
Div Payout % 34.93% - 75.27% - 31.92% - 74.71% -
Equity
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Net Worth 179,045 190,050 181,850 179,125 187,340 176,143 169,354 3.78%
NOSH 138,794 138,723 138,817 138,856 138,770 138,695 138,815 -0.01%
Ratio Analysis
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
NP Margin 19.59% 20.66% 19.87% 20.72% 22.93% 17.70% 19.23% -
ROE 17.75% 17.61% 17.75% 17.99% 18.56% 15.21% 15.36% -
Per Share
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
RPS 116.89 116.77 116.99 112.03 109.28 109.12 97.47 12.91%
EPS 22.90 24.12 23.25 23.21 25.06 19.32 18.74 14.34%
DPS 8.00 0.00 17.50 0.00 8.00 0.00 14.00 -31.20%
NAPS 1.29 1.37 1.31 1.29 1.35 1.27 1.22 3.80%
Adjusted Per Share Value based on latest NOSH - 138,773
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
RPS 16.87 16.84 16.88 16.17 15.77 15.73 14.07 12.89%
EPS 3.30 3.48 3.36 3.35 3.62 2.79 2.70 14.35%
DPS 1.15 0.00 2.53 0.00 1.15 0.00 2.02 -31.38%
NAPS 0.1861 0.1976 0.189 0.1862 0.1948 0.1831 0.1761 3.76%
Price Multiplier on Financial Quarter End Date
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Date 30/06/14 31/03/14 31/12/13 30/09/13 28/06/13 29/03/13 31/12/12 -
Price 2.97 3.03 2.58 2.55 2.38 2.23 2.13 -
P/RPS 2.54 2.59 2.21 2.28 2.18 2.04 2.19 10.41%
P/EPS 12.97 12.56 11.10 10.99 9.50 11.54 11.37 9.20%
EY 7.71 7.96 9.01 9.10 10.53 8.66 8.80 -8.46%
DY 2.69 0.00 6.78 0.00 3.36 0.00 6.57 -44.95%
P/NAPS 2.30 2.21 1.97 1.98 1.76 1.76 1.75 20.04%
Price Multiplier on Announcement Date
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Date 26/08/14 20/05/14 26/02/14 19/11/13 28/08/13 27/05/13 25/02/13 -
Price 3.37 3.09 2.60 2.56 2.44 2.51 2.17 -
P/RPS 2.88 2.65 2.22 2.29 2.23 2.30 2.23 18.64%
P/EPS 14.72 12.81 11.18 11.03 9.74 12.99 11.58 17.39%
EY 6.80 7.81 8.94 9.07 10.27 7.70 8.64 -14.79%
DY 2.37 0.00 6.73 0.00 3.28 0.00 6.45 -48.79%
P/NAPS 2.61 2.26 1.98 1.98 1.81 1.98 1.78 29.15%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment